Li Wan-Fen, Sun Chien-Wen, Cheng Tain-Junn, Chang Kuang-Hsi, Chen Chien-Jen, Wang Shu-Li
Division of Environmental Health and Occupational Medicine, National Health Research Institutes, Zhunan, Taiwan.
Toxicol Appl Pharmacol. 2009 Apr 15;236(2):246-53. doi: 10.1016/j.taap.2009.01.019. Epub 2009 Feb 5.
To understand whether human paraoxonase 1 (PON1) would modulate the risk for arsenic-related atherosclerosis, we studied 196 residents from an arseniasis-endemic area in Southwestern Taiwan and 291 age- and sex-matched residents from a nearby control area where arsenic exposure was found low. Carotid atherosclerosis was defined by a carotid artery intima-media wall thickness (IMT) of >1.0 mm. Prevalence of carotid atherosclerosis was increased in the arseniasis-endemic area as compared to the control area after adjustment for conventional risk factors (OR=2.20, p<0.01). The prevalence was positively associated with cumulative arsenic exposure (mg/L-year) in a dose-dependent manner. Multiple logistic regression analysis showed that in the endemic group, low serum PON1 activity was an independent risk factor for atherosclerosis (OR=4.18 low vs. high, p<0.05). For those of low PON1 activity and high cumulative arsenic exposure, the odds ratio for the prevalence of atherosclerosis was further increased up to 5.68 (p<0.05). No significant association was found between atherosclerosis and four polymorphisms of the PON gene cluster (PON1 -108C/T, PON1 Q192R, PON2 A148G, PON2 C311S). However, genetic frequencies of certain alleles including PON1 Q192, PON2 G148 and PON2 C311 were found increased in the endemic group as compared to the controls and a general Chinese population, indicating a possible survival selection in the endemic group after a long arsenic exposure history. Our results showed a significant joint effect between arsenic exposure and serum PON1 activity on carotid atherosclerosis, suggesting that subjects of low PON1 activity may be more susceptible to arsenic-related cardiovascular disease.
为了解人对氧磷酶1(PON1)是否会调节砷相关动脉粥样硬化的风险,我们研究了来自台湾西南部砷中毒流行地区的196名居民,以及来自附近砷暴露水平较低的对照地区的291名年龄和性别匹配的居民。颈动脉粥样硬化定义为颈动脉内膜中层厚度(IMT)>1.0毫米。在调整传统风险因素后,与对照地区相比,砷中毒流行地区颈动脉粥样硬化的患病率有所增加(OR=2.20,p<0.01)。患病率与累积砷暴露(毫克/升-年)呈剂量依赖性正相关。多因素逻辑回归分析显示,在流行组中,血清PON1活性低是动脉粥样硬化的独立危险因素(低活性组与高活性组相比,OR=4.18,p<0.05)。对于PON1活性低且累积砷暴露高的人群,动脉粥样硬化患病率的优势比进一步增加至5.68(p<0.05)。未发现动脉粥样硬化与PON基因簇的四种多态性(PON1 -108C/T、PON1 Q192R、PON2 A148G、PON2 C311S)之间存在显著关联。然而,与对照组和一般中国人群相比,发现流行组中某些等位基因的基因频率增加,包括PON1 Q192、PON2 G148和PON2 C311,这表明在长期砷暴露史后,流行组可能存在生存选择。我们的结果显示,砷暴露与血清PON1活性对颈动脉粥样硬化有显著的联合作用,表明PON1活性低的个体可能更容易患砷相关心血管疾病。